Abstract
Cancer and diabetes are two highly malignant diseases. Accumulating evidence suggests that cancer incidence might be associated with diabetes mellitus, especially Type-2 diabetes which is characterized by hyperinsulinemia, hyperglycemia, obesity, and overexpression of multiple components of the WNT pathway. These diabetes risk factors can activate a number of signaling pathways that are important in the development of different cancers. To systematically understand the signaling components that link diabetes and cancer risk, we have constructed a single-cell, synchronous Boolean network model by integrating the signaling pathways that are influenced by these risk factors. Then, we have applied Model Checking, a formal verification approach, to qualitatively study several temporal logic properties of our diabetes-cancer model. Our aim was to study insulin resistance, cancer cell proliferation and apoptosis. The verification results show that the diabetes risk factors might not increase cancer risk in normal cells, but they will promote cell proliferation if the cell is in a precancerous or cancerous stage characterized by losses of the tumor-suppressor proteins ARF and INK4a.
Keywords: Apoptosis, boolean network, cancer, diabetes, model checking, signaling pathway, temporal logic, Glucose-AMPK-mTOR, Insulin-PI3K, Obesity-ROS-JNK
Current Bioinformatics
Title:Model Checking a Synchronous Diabetes-Cancer Logical Network
Volume: 8 Issue: 1
Author(s): Haijun Gong, Paolo Zuliani and Edmund M. Clarke
Affiliation:
Keywords: Apoptosis, boolean network, cancer, diabetes, model checking, signaling pathway, temporal logic, Glucose-AMPK-mTOR, Insulin-PI3K, Obesity-ROS-JNK
Abstract: Cancer and diabetes are two highly malignant diseases. Accumulating evidence suggests that cancer incidence might be associated with diabetes mellitus, especially Type-2 diabetes which is characterized by hyperinsulinemia, hyperglycemia, obesity, and overexpression of multiple components of the WNT pathway. These diabetes risk factors can activate a number of signaling pathways that are important in the development of different cancers. To systematically understand the signaling components that link diabetes and cancer risk, we have constructed a single-cell, synchronous Boolean network model by integrating the signaling pathways that are influenced by these risk factors. Then, we have applied Model Checking, a formal verification approach, to qualitatively study several temporal logic properties of our diabetes-cancer model. Our aim was to study insulin resistance, cancer cell proliferation and apoptosis. The verification results show that the diabetes risk factors might not increase cancer risk in normal cells, but they will promote cell proliferation if the cell is in a precancerous or cancerous stage characterized by losses of the tumor-suppressor proteins ARF and INK4a.
Export Options
About this article
Cite this article as:
Gong Haijun, Zuliani Paolo and M. Clarke Edmund, Model Checking a Synchronous Diabetes-Cancer Logical Network, Current Bioinformatics 2013; 8 (1) . https://dx.doi.org/10.2174/1574893611308010004
DOI https://dx.doi.org/10.2174/1574893611308010004 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pathogenesis and Subtype of Intracerebral Hemorrhage (ICH) and ICH Score Determines Prognosis
Current Neurovascular Research Targeting the Akt Kinase to Modulate Survival, Invasiveness and Drug Resistance of Cancer Cells
Current Medicinal Chemistry Tigecycline: A New Treatment Choice Against Acinetobacter baumannii
Recent Patents on Anti-Infective Drug Discovery Hypertension in Diabetes: Optimal Pharmacotherapy
Cardiovascular & Hematological Agents in Medicinal Chemistry Targeted Metabolomics Reveals Hippurate as a Urinary Potential Marker for Diabetic Nephropathy
Current Metabolomics The Role of White Matter Abnormalities in Treatment-Resistant Depression: A Systematic Review
Current Pharmaceutical Design Bile Acids as Novel Pharmacological Agents: The Interplay Between Gene Polymorphisms, Epigenetic Factors and Drug Response
Current Pharmaceutical Design Genetic Variant-Associated Endothelial Dysfunction Behind Small-Vessel Cerebral Circulatory Disorders: A New Pathomechanism Behind Common Cerebral Phenotypes
Mini-Reviews in Medicinal Chemistry The Anti-Inflammatory Effects of Statins on Coronary Artery Disease: An Updated Review of the Literature
Current Cardiology Reviews Benefits of SGLT2 Inhibitors Beyond Glycemic Control – A Focus on Metabolic, Cardiovascular and Renal Outcomes
Current Diabetes Reviews The Predictive Value of Lipid Markers in Vascular Disease
Current Pharmaceutical Design Editorial (Mini-Thematic Issue: Social Media and Smart Technology in Diabetes: - One Small Step…..One Giant Leap.)
Current Diabetes Reviews The Role of Alpha-lipoic Acid Supplementation in the Prevention of Diabetes Complications: A Comprehensive Review of Clinical Trials
Current Diabetes Reviews Genetics and Vaccines in the Era of Personalized Medicine
Current Genomics Endothelin Receptors, Mitochondria and Neurogenesis in Cerebral Ischemia
Current Neuropharmacology Molecular Docking Studies of Novel Arylidene-2, 4-Thiazolidinediones as Potential Aldose Reductase Inhibitors
Letters in Drug Design & Discovery Design, Synthesis and Biological Evaluation of Antipicornaviral Pyrrole-Containing Peptidomimetics
Protein & Peptide Letters Metaboloepigenetics: The Emerging Network in Stem Cell Homeostasis Regulation
Current Stem Cell Research & Therapy Preventive Antiretroviral Therapy in Non-Thalassemia Carrier Infants Exposed to Mother-to-Child Transmission of HIV Decreases Cord and After Delivery Red Blood Production without Altering the Development of Hemoglobin
Current HIV Research Electrochemical Measurement of Antidiabetic Potential of Medicinal Plants Using Screen-printed Carbon Nanotubes Electrode
Current Nanoscience